Teladoc Health, Inc. (NYSE:TDOC) Shares Acquired by Federated Hermes Inc.

Federated Hermes Inc. lifted its position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 18.1% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 398,791 shares of the health services provider's stock after purchasing an additional 61,194 shares during the quarter. Federated Hermes Inc. owned approximately 0.23% of Teladoc Health worth $3,174,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of TDOC. Point72 Asset Management L.P. raised its holdings in Teladoc Health by 33.6% during the fourth quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock worth $101,625,000 after purchasing an additional 2,813,568 shares in the last quarter. Maple Rock Capital Partners Inc. raised its stake in shares of Teladoc Health by 189.5% during the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock worth $32,369,000 after buying an additional 2,331,000 shares in the last quarter. Two Sigma Investments LP acquired a new stake in shares of Teladoc Health in the 4th quarter valued at approximately $18,348,000. Two Sigma Advisers LP boosted its stake in shares of Teladoc Health by 213.0% in the fourth quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider's stock valued at $20,532,000 after buying an additional 1,537,094 shares in the last quarter. Finally, Vanguard Group Inc. grew its holdings in Teladoc Health by 5.9% during the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock worth $167,830,000 after acquiring an additional 1,029,829 shares during the period. 76.82% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, insider Carlos Nueno sold 3,958 shares of the company's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $6.86, for a total transaction of $27,151.88. Following the completion of the transaction, the insider owned 17,645 shares of the company's stock, valued at $121,044.70. This represents a 18.32% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Adam C. Vandervoort sold 5,808 shares of the business's stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total transaction of $39,842.88. Following the completion of the sale, the insider owned 69,773 shares of the company's stock, valued at approximately $478,642.78. The trade was a 7.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 18,656 shares of company stock valued at $128,189 in the last quarter. 0.58% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

TDOC has been the subject of a number of recent analyst reports. Jefferies Financial Group reduced their target price on Teladoc Health from $10.00 to $8.00 and set a "hold" rating for the company in a report on Monday, April 21st. Stifel Nicolaus cut their price target on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a report on Thursday, May 1st. Mizuho started coverage on shares of Teladoc Health in a report on Friday, July 25th. They set a "neutral" rating and a $10.00 price objective on the stock. Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a research report on Thursday, May 1st. Finally, Wells Fargo & Company reduced their price target on shares of Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a research report on Thursday, May 8th. Twelve analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $9.76.

Teladoc Health Price Performance

Shares of TDOC traded up $0.02 during trading hours on Wednesday, reaching $6.98. 7,678,618 shares of the company traded hands, compared to its average volume of 7,042,202. The stock has a market capitalization of $1.23 billion, a PE ratio of -5.86 and a beta of 1.76. The stock has a fifty day simple moving average of $7.71 and a 200 day simple moving average of $8.47. Teladoc Health, Inc. has a fifty-two week low of $6.35 and a fifty-two week high of $15.21. The company has a quick ratio of 2.58, a current ratio of 2.67 and a debt-to-equity ratio of 0.70.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, topping analysts' consensus estimates of ($0.27) by $0.08. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The business had revenue of $631.90 million during the quarter, compared to the consensus estimate of $621.91 million. During the same period in the previous year, the firm posted ($0.38) earnings per share. The company's quarterly revenue was down 1.6% compared to the same quarter last year. As a group, research analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.